Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Management
Volume 2017, Article ID 7212713, 7 pages
https://doi.org/10.1155/2017/7212713
Clinical Study

Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial

1Tom Baker Cancer Centre and Division of Palliative Medicine, University of Calgary, 1331 29 Street NW, Calgary, AB, T2N4N2, Canada
2ClinForce Services Inc., Vancouver, BC, Canada
3PRA Health Sciences, Victoria, 655 Tyee Rd., Victoria, BC, Canada V9A 6X5
4Statcon Consulting Services, 6 Matson Drive, Caledon, ON, Canada L7E 0A3
5Département d’Anesthésiologie, CHUM, 1560, rue Sherbrooke Est, Pavillon Deschamps, Local FS-1136, Montréal, QC, Canada H2L 4M1
6St. Paul’s Hospital, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6
7Département de Pharmacologie et Physiologie, Faculté de Médecine, Université de Montréal, CP 6128 Centre-Ville, Montréal, QC, Canada H3C 3J7
8WEX Pharmaceuticals Inc., 420-1090 West Pender Street, Vancouver, BC, Canada V6E 2N7
9Clinical Research Unit, Jewish General Hospital, Room E-872 3755, Chemin de la Côte Sainte-Catherine, Montréal, QC, Canada H3T 1E2

Correspondence should be addressed to Neil A. Hagen; moc.liamg@5negahlien

Received 15 September 2016; Accepted 23 March 2017; Published 7 May 2017

Academic Editor: Jacob Ablin

Copyright © 2017 Neil A. Hagen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Neil A. Hagen, Lyne Cantin, John Constant, et al., “Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial,” Pain Research and Management, vol. 2017, Article ID 7212713, 7 pages, 2017. https://doi.org/10.1155/2017/7212713.